title: Managing severe anemia when the patient is a Jehovah's Witness.
authors.affiliation: Blood Conservation Program, Saint Luke's Hospital, Kansas City, Missouri, USA.
authors.forename: Shannon
authors.initials: S
authors.lastname: Lynn
authors.forename: Janet
authors.initials: J
authors.lastname: McDaniel
mesh_terms: D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000188:drug therapy* / Q000628:therapy; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use; D005290:Ferric Compounds / Q000627:therapeutic use; D000077605:Ferric Oxide, Saccharated; D005296:Ferrous Compounds / Q000627:therapeutic use; D005440:Fluid Therapy; D005937:Glucaric Acid / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D033221:Jehovah's Witnesses; D008297:Male; D010102:Oxygen Inhalation Therapy; D011994:Recombinant Proteins / Q000627:therapeutic use; D012720:Severity of Illness Index; D014805:Vitamin B 12 / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
chemical_list: D005290:Ferric Compounds; D005296:Ferrous Compounds; D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D014803:Vitamin B Complex; C020748:ferrous sulfate; D000068817:Epoetin Alfa; D000077605:Ferric Oxide, Saccharated; D014805:Vitamin B 12; D005937:Glucaric Acid